Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

129

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N02AA01	SKENAN LP	G	Morphine sulfate - 30mg	30mg	Capsule, prolonged release microgranules	972,942 L.L
N02AA01	ACTISKENAN	G	Morphine sulfate - 30mg	30mg	Capsule, immediate release	763,303 L.L
A02BC06	DEXILANT	B	Dexlansoprazole - 30mg	30mg	Capsule, delayed release	1,595,141 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 30mg	30mg	Injectable powder for suspension+diluent	57,182,544 L.L
L04AA32	OTEZLA	B	Apremilast - 30mg	30mg	Tablet, film coated	49,829,454 L.L
L04AA32	APRIVA	G	Apremilast - 30mg	30mg	Tablet, film coated	41,455,526 L.L
N06AX11	REMERON SOLTAB	B	Mirtazapine - 30mg	30mg	Tablet, orodispersible	1,486,290 L.L
N06AX11	MIRTA TAD	G	Mirtazapine - 30mg	30mg	Tablet, film coated	1,138,235 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 30mg	30mg	Injectable powder for suspension+diluent	L.L
N06AX21	DULOXA 30	G	Duloxetine HCl - 30mg	30mg	Capsule, delayed release	716,716 L.L
N06AX21	LOXYT 30	G	Duloxetine HCl - 30mg	30mg	Capsule, delayed release	716,716 L.L
N06AX21	PMS-DULOXETINE	G	Duloxetine HCl - 30mg	30mg	Capsule, delayed release	642,357 L.L
N06AX21	DULOXETINE BIOGARAN	G	Duloxetine HCl - 30mg	30mg	Capsule, gastro-resistant	573,821 L.L
G03AD02	ELLAONE	B	Ulipristal acetate - 30mg	30mg	Tablet	2,276,469 L.L
G03AD02	ECINQ	G	Ulipristal acetate - 30mg	30mg	Tablet, film coated	1,302,183 L.L
H02AB13	DEFAL	B	Deflazacort - 30mg	30mg	Tablet	635,638 L.L
L01CA04	NAVELBINE	B	Vinorelbine (ditartrate) - 30mg	30mg	Capsule, soft gelatin	6,072,824 L.L
C08CA05	NIFELAT 30 LA	G	Nifedipine - 30mg	30mg	Tablet, prolonged release	1,007,882 L.L
C08CA06	NIMOTOP	B	Nimodipine - 30mg	30mg	Tablet, film coated	581,884 L.L
L01CD01	PACLITAXEL NEAPOLIS	G	Paclitaxel - 30mg	30mg	Injectable concentrate for solution	3,514,148 L.L
H05BX01	CINACALCET ARROW	BioTech	Cinacalcet - 30mg	30mg	Tablet, coated	8,768,039 L.L
R03DX10	FASENRA	B	Benralizumab - 30mg	30mg	Injectable solution	L.L
R03DX10	FASENRA	B	Benralizumab - 30mg	30mg	Injectable solution	214,213,273 L.L
M01AB15	KETOLAC	G	Ketorolac trometamine - 30mg/2ml	30mg/2ml	Injectable solution	106,164 L.L
N04BC07	DACEPTON	G	Apomorphine HCl - 30mg/3ml	30mg/3ml	Injectable solution	13,404,432 L.L
R05CB06	MUCOSOLVAN	B	Ambroxol HCl - 30mg/5ml	30mg/5ml	Syrup	380,307 L.L
R05CB06	MUCOVIC FORTE	G	Ambroxol HCl - 30mg/5ml	30mg/5ml	Solution, sugar free	293,086 L.L
R05CB06	MUCOVIC FORTE	G	Ambroxol HCl - 30mg/5ml	30mg/5ml	Solution, sugar free	440,268 L.L
R05CB06	MUKORAL	G	Ambroxol HCl - 30mg/5ml	30mg/5ml	Syrup	341,336 L.L
L01CD01	EBETAXEL	G	Paclitaxel - 30mg/5ml	30mg/5ml	Injectable concentrated solution	2,983,330 L.L

...

129

...